Azathioprine, a well-known immunosuppressive agent, is used extensively in renal transplantation. There have been several case reports of pure red cell aplasia induced by this drug following a successful kidney transplant. Previous management of azathioprine-induced red cell aplasia included reduction of azathioprine dose, or treatment with cyclophosphamide. We propose the substitution of cyclosporine for azathioprine, in this clinical setting. Not only does cyclosporine allow recovery of bone marrow function, but it maintains a level of immunosuppression which stabilizes renal function in the post-transplant patient.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bach JB, Dardenne M (1971) The metabolism of azathioprine in renal failure. Transplantation 12: 253–259
Klippel JH, Decker JL (1974) Relative macrocytosis in cyclophosphamide and azathioprine therapy. JAMA 229: 180–181
Wickramasighe SN, Dodsworth H, Rault RMJ, Hulme B (1974) Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplant. Transplantation 18: 443–446
McGrath BP, Ibels LS, Raik E, Hargrave M, Mahony JF, Stewart JH (1975) Erythroid toxicity of azathioprine: macrocytosis and selective marrow hypoplasia. QJ Med 44: 57–63
DeClerck YA, Ettenger RB, Orkga JA, Pennisi AJ (1980) Macrocytosis and pure RBC anemia caused by azathioprine. Am J Dis Child 134: 377–379
Old CW, Flannery EP, Grogan TM, Stone WH, SanAntonio RP (1978) Azathioprine-induced pure red cell aplasia. JAMA 240: 552–554
Hogge DE, Wilson DR, Shumat KH, Caltram DC (1982) Reversible azathioprine-induced erythrocyte aplasia in a renal transplant recipient. Can Med Assoc J 126: 512–513
Handschumacher RE (1990) Immunosuppressive drug. In: Goodman L, Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 1264–1276
Alexander SR, Arbus GS, Butt KMH, Conley S, Fine RN, Greifer I, Gruskin AB, Harmon WE, McEnery PT, Nevins TE, Nogueira N, Salvatierra O, Tejani A (1990) The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 4: 542–553
Kahan BD (1989) Cyclosporine. N Engl J Med 321: 1725–1738
Penn I (1987) Cancers following cyclosporine therapy. Transplantation 43: 32–35
About this article
Cite this article
Vogt, B., Fivush, B.A. Cyclosporine in the treatment of azathioprine-induced red cell aplasia following renal transplantation. Pediatr Nephrol 6, 278–279 (1992). https://doi.org/10.1007/BF00878378
- Red cell aplasia
- Renal transplantation